{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:19Z","timestamp":1789055659164,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP) is a prevalent respiratory infection. Refractory MPP (RMPP) presents more severe symptoms and requires more intensive treatment compared to general MPP (GMPP). This study aimed to identify distinguishing clinical, laboratory, and radiological characteristics between RMPP and GMPP and develop an early predictive model for RMPP risk stratification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 568 patients, including 130 RMPP cases and 438 GMPP cases, were enrolled. Clinical information, laboratory tests, and radiological features were compared. Univariate and multivariate logistic regression analyses identified serum biomarkers associated with RMPP. A combined predictive model using random forest approach was developed and externally validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RMPP patients showed significantly higher rates of older age, fever, tachypnea, chest tightness, wheezing, chills, extrapulmonary complications, decreased unilateral lung sounds, longer fever duration, hospital stay, antibiotic therapy, oxygenotherapy use, and Intensive Care Unit (ICU) admission (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Laboratory findings revealed elevated neutrophil percentage, C-reactive protein (CRP), lactate dehydrogenase (LDH), immunoglobulin A (IgA), interleukin (IL)-6, IL-10, and interferon-gamma (IFN-\u03b3), but lower prealbumin (PAB) concentrations in RMPP. Radiologically, RMPP exhibited more severe manifestations such as large lesions, pleural effusion, lobar atelectasis, pulmonary consolidation, and pleural thickening. Using the eight independently associated serum biomarkers, we developed a multi-factor random forest model that showed excellent discrimination between RMPP and GMPP (AUC\u2009=\u20090.978 in the development cohort), which was confirmed in an external validation cohort (AUC\u2009=\u20090.957).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant differences in clinical, laboratory, and radiological characteristics were observed between RMPP and GMPP. The combined multi-marker model shows strong potential for early risk identification of RMPP and may support timely clinical decision-making; however, prospective validation is needed before routine implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1680913","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:16:47Z","timestamp":1771503407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening of early predictive serum biomarkers and construction of a combined predictive model for refractory Mycoplasma pneumoniae infection in children"],"prefix":"10.3389","volume":"14","author":[{"given":"Ling","family":"Zhu","sequence":"first","affiliation":[{"name":"Pediatrics Unit, Nanjing Jiangbei Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Pediatrics Unit, Nanjing Jiangbei Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Nanjing Jiangbei Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Medicine, Clinical Medical College of Anhui Medical University","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Pediatrics Unit, Nanjing Jiangbei Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/jcm11102824","article-title":"Refractory mycoplasma pneumoniae pneumonia in children: early recognition and management","volume":"11","author":"Tong","year":"2022","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16442","DOI":"10.1038\/s41598-017-16652-3","article-title":"A sensitive and rapid immunoassay for Mycoplasma pneumoniae in children with pneumonia based on single-walled carbon nanotubes","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1306234","DOI":"10.3389\/fped.2023.1306234","article-title":"Global research trends of mycoplasma pneumoniae pneumonia in children: a bibliometric analysis","volume":"11","author":"Song","year":"2023","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00431-022-04761-9","article-title":"Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model","volume":"182","author":"Zhang","year":"2023","journal-title":"Eur J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","article-title":"Rational stepwise approach for mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Tsai","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12890-023-02684-1","article-title":"Recognition of refractory mycoplasma pneumoniae pneumonia among mycoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model","volume":"23","author":"Li","year":"2023","journal-title":"BMC Pulm Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/pathogens10020119","article-title":"Mycoplasma pneumoniae infections: pathogenesis and vaccine development","volume":"10","author":"Jiang","year":"2021","journal-title":"Pathogens"},{"key":"B8","doi-asserted-by":"publisher","first-page":"107480","DOI":"10.1016\/j.rmed.2023.107480","article-title":"Chest imaging classification in mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes","volume":"221","author":"Huang","year":"2024","journal-title":"Respir Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/crj.13620","article-title":"Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children","volume":"17","author":"Fan","year":"2023","journal-title":"Clin Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","article-title":"Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis","volume":"21","author":"Ahn","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7196\/AJTCCM.2020.v26i3.104","article-title":"Diagnosis and management of community-acquired pneumonia in children: south African thoracic society guidelines","volume":"26","author":"Moore","year":"2020","journal-title":"Afr J Thorac Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"813614","DOI":"10.3389\/fped.2022.813614","article-title":"Development of a nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children","volume":"10","author":"Shen","year":"2022","journal-title":"Front Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/jcm11020306","article-title":"Clinical characteristics of macrolide-refractory Mycoplasma pneumoniae pneumonia in Korean children: a multicenter retrospective study","volume":"11","author":"Choi","year":"2022","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3345\/cep.2020.01305","article-title":"Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia","volume":"64","author":"Cho","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e39375","DOI":"10.1097\/MD.0000000000039375","article-title":"Predictive clinical indicators of refractory mycoplasma pneumoniae pneumonia in children: a retrospective cohort study","volume":"103","author":"Pei","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9227838","DOI":"10.1155\/2022\/9227838","article-title":"Refractory mycoplasma pneumonia in children: a systematic review and meta-analysis of laboratory features and predictors","volume":"2022","author":"Huang","year":"2022","journal-title":"J Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37037","DOI":"10.1038\/srep37037","article-title":"Cytokines as the good predictors of refractory mycoplasma pneumoniae pneumonia in school-aged children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41598-021-81853-w","article-title":"The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8354892","DOI":"10.1155\/2018\/8354892","article-title":"Serum tumor necrosis factor-\u03b1 and interferon-\u03b3 levels in pediatric mycoplasma pneumoniae pneumonia: a systematic review and meta-analysis","volume":"2018","author":"Wang","year":"2018","journal-title":"Can Respir J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1302702","DOI":"10.3389\/fimmu.2023.1302702","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e97680","DOI":"10.5812\/ijp.97680","article-title":"Prealbumin may predict clinical outcomes in children with severe Mycoplasma pneumoniae pneumonia","volume":"30","author":"Wang","year":"2020","journal-title":"Int J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e24894","DOI":"10.1097\/MD.0000000000024894","article-title":"The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis","volume":"100","author":"Gong","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"18029","DOI":"10.1038\/s41598-025-02962-4","article-title":"Predicting and interpreting key features of refractory mycoplasma pneumoniae pneumonia using multiple machine learning methods","volume":"15","author":"Jiang","year":"2025","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","article-title":"Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study","volume":"20","author":"Choi","year":"2019","journal-title":"Respir Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1186\/s12879-025-11133-9","article-title":"Predictive value of an early comprehensive assessment model for refractory mycoplasma pneumoniae pneumonia and internal validation","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-020-01577-9","article-title":"The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study","volume":"22","author":"Wen","year":"2021","journal-title":"Respir Res"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1680913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:16:48Z","timestamp":1771503408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1680913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":28,"alternative-id":["10.3389\/fped.2026.1680913"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1680913","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1680913"}}